Theme Paper for Discussion - Effective Drug Regulation: What Can Countries Do?, Geneva, 16-19 March 1999
(1999; 53 pages) [French] View the PDF document
Table of Contents
View the documentAcknowledgements
View the documentAcronyms and abbreviations
View the documentExecutive summary
Open this folder and view contents1. Drug regulation: an early concern
View the document2. Rationale for regulating drugs
View the document3. Where are we today?
Close this folder4. How can drug regulation be made effective?
View the document4.1 Assess drug regulation performance
View the document4.2 Identify and develop priority functions
View the document4.3 Provide a clear mission and purpose
View the document4.4 Create a supportive environment
View the document4.5 Formulate adequate drug legislation
View the document4.6 Create appropriate organizational structure
View the document4.7 Allocate adequate human and financial resources
View the document4.8 Minimize corruption and conflict of interest
View the document4.9 Apply most appropriate strategy
View the document5. The way forward
View the documentAnnex 1. Status of drug regulation and drug quality assurance in WHO African Region and selected countries
View the documentAnnex 2. A model framework for assessing drug regulation
View the documentAnnex 3. Possible approaches to developing drug regulation a
View the documentAnnex 4. Examples of mission statements concerning drug regulation
View the documentAnnex 5. Fees collected for drug registration
View the documentReferences
 

4.5 Formulate adequate drug legislation

Drug legislation forms the basis of drug regulation. It must be comprehensive and enforceable if it is to be effective. Countries should therefore update their drug legislation if it is obsolete or inadequate. Important determining factors of the effectiveness of drug legislation include the extent to which the legislative framework is in accord with national policies, the degree of regulation which the government considers desirable and practicable to exercise, and the situation in its country’s pharmaceutical sector.

In particular, drug legislation should be sufficiently comprehensive and flexible to meet the objectives of drug regulation. Flexibility can be achieved by adopting a basic drug law and giving the executive branch of the government the authority to formulate the detailed requirements of drug regulations. In general, drug legislation must:

• define the areas and activities to be regulated;

• state the roles, responsibilities, rights and functions of all parties involved with drug regulation, including those of the regulators and regulates;

• create the administrative bodies necessary for implementation of drug regulation, and define their structural and functional relationships;

• set the qualifications and standards required for those handling drugs;

• create mechanisms to ensure that all responsible parties are licensed and inspected to ensure compliance with the provisions of drug legislation, as well as with the standards and specifications set for persons, premises and practices;

• define the norms, standards and specifications necessary for ensuring the safety, efficacy and quality of drug products, as well as the appropriateness and accuracy of drug information;

• state the terms and conditions under which licences to import, manufacture, distribute, sell, supply and promote drugs will be suspended, revoked or cancelled;

• establish the administrative measures and legal sanctions that will apply when provisions of drug legislation are violated.

to previous section to next section
 

Last updated: January 19, 2012